Spring 2023

Inside this issue: FDA Approves OTC Naloxone, Poison Help Chat, Mail-Back Envelopes for Opioid Medications, NPPW Recap, Pediatric Exposures to Edible Cannabis, Dangers of Mercury in Cosmetics